Last week, I attended a webinar that showcased the results of a study on the adoption of clinical trial software in life sciences. The study was conducted by a working group led by the Tufts Center for the Study of Drug Development, CDISC, and Oracle Health Sciences, and the results reiterated what we already […]
Life Sciences
A Card That Fits In Your Genes
A few days ago, I read an article in The Atlantic about precision medicine. But it wasn’t about developing drugs for individuals with specific biomarkers. Instead, it discussed a simpler form of precision medicine that can prevent serious adverse events (SAEs). This method can actually fit in your wallet. It’s a card that houses […]
A Cleanse That’s Good For Your Clinical Data
Oracle recently created a short video that explains what Data Management Workbench (DMW) is all about. In short, DMW is an application that is part of Oracle’s clinical data warehousing suite that’s designed to combine data from various data sources and third-party providers, and transform it into standard data models. In addition to the […]
New FDA Warning Letter Highlights Importance Of CAPAs
On September 24, 2015, the FDA issued a Warning Letter to a manufacturer and distributor of medical devices for several violations. While the issues at hand may not seem severe, they do put the public at risk and reduce the confidence that the FDA has in the organization. Plus, they are inviting unwanted scrutiny […]
Attaching Supportive Info To CAPA Records In Argus Safety
We recently talked about Argus Safety’s ability to able to uniquely identify cases. Today, we’ll touch upon how Oracle’s drug safety and pharmacovigilance system supports CAPA rule #3.
93 More Companies Chose Oracle Health Sciences Solutions
And that was just this past year. So, I think it’s fair to say that Oracle’s software is the cream of the crop in the life sciences and healthcare industries. According to a press release issued by the company, close to 100 life sciences companies have signed on to use Oracle’s clinical and safety […]
3 Ways Life Sciences Can Jumpstart Digital Transformation
I recently read an article from McKinsey & Company about the digital revolution that needs to occur in order for the life sciences industry to be successful in today’s age. This is the same digital revolution that helped transform other industries, such as financial and retail. Like I mentioned in one of my previous blog […]
10 Tips On How To Discuss Genome Sequencing With Family Members
In 2009, the cost for a consumer to sequence his or her genome was $49,000. It’s all the way down to $1,000 today. As the price continues to become more affordable, the frequency of the average Joe sequencing his genome will likely increase. However, many individuals are wary of the idea of knowing more […]
Release Notes: Oracle/Perficient’s Clinical Apps [Oct. 2015]
Perficient’s Life Sciences practice regularly monitors the software release notes for several Oracle Health Sciences applications, as well as our own clinical and safety systems. The systems covered in our review are:
Top 5 Life Sciences Blog Posts From September 2015
Now that October is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in September – they’re ranked in order of popularity, with number one being the most viewed piece.
How Roche’s App Will Shape The Future Of Parkinson’s Disease
Check this out. Roche just developed a mobile app, which is currently being evaluated in a Phase I trial, that can help assess the severity of one’s Parkinson’s disease (PD). Here’s how it works: Patients are provided with pre-configured smartphones and, over time, are guided through a series of tests to collect data points. […]
Were Kim Kardashian’s Instagram Posts Worth It?
Since the infamous Kim Kardashian Instagram post went up and the FDA issued a Warning Letter to Duchesnay, the company she was representing, a couple of things have happened. For one, Kim has issued a corrective post (i.e., ad), which outlined the safety information for Diclegis, the medication for morning sickness she is promoting. And, […]